Genome Sequencing and Characterization of BDBV in Current Outbreak
Food and Drug Administration · United States
Time Left to Bid
Awarded
Basic information
- Reference number
- 75F40126C00106
- Issuing organization
- Food and Drug Administration · Find award history →
- Government level
- Federal
- Solicitation type
- Education & Training
- Title
- Genome Sequencing and Characterization of BDBV in Current Outbreak
- Source
- USASpending (Federal)
- Source ID
- usa-75F40126C00106
Details
- Location
- United States
Summary
This project involves sequencing and characterizing the genome of BDBV (a pathogenic virus) during an active outbreak. The work targets analysis of viral genomes from approximately 1,000 patient samples to support outbreak response and epidemiological understanding. The project is awarded to the University of Liverpool under a definitive contract with the FDA.
Description
EO 14398 - THIS PROJECT SHALL SEQUENCE AND CHARACTERIZE THE GENOME OF BDBV IN THE CURRENT OUTBREAK, WITH A SPECIFIC TARGET TO SEQUENCE AND ANALYZE THE BDBV GENOME FROM AS MANY AS 1,000 PATIENTS Awarded to: UNIVERSITY OF LIVERPOOL Agency: Department of Health and Human Services Sub-agency: Food and Drug Administration Award type: DEFINITIVE CONTRACT
Dates
- Publication
- 2026/08/21 12:00:00 AM UTC
- Closing date
- 2027/02/20 12:00:00 AM UTC
Estimated value
$350K USD
Classification
Normalized category